Ind-Swift Laboratories Limited
Incorporated in 1995, Ind-Swift Laboratories Ltd is in the business of Bulk Drugs & Pharmaceuticals
What Ind-Swift files
- Others65
- Important25
- Updates24
- Board Meeting13
- Insider Trade6
- QIP/Rights/Pref.6
**1. Business Performance:** Ind-Swift Labs reported strong Q1FY27, reflecting its transformation into a focused Finished Dosage Formulation (FDF) manufacturer. Operating EBITDA jumped 2.85x YoY to ₹33.32 Cr, with margins at 17.91%. Revenue grew 21.16% YoY to ₹186.08 Cr, and PAT (excluding exceptional items) surged 2.04x YoY to ₹24.68 Cr, with...
Ind-Swift Laboratories' Q3 FY26 saw revenue reach ₹177.06 Cr. Operating EBITDA grew 6.60% quarter-over-quarter to ₹9.11 Cr (5.95% margin), while Net Profit jumped 22.60% QoQ to ₹10.74 Cr (6.07% margin). This efficiency gain followed a historic strategic reset, including the ₹1,650 Cr divestment of its API & CRAMS business and...